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Abstract – Methicillin-resistant Staphylococcus aureus (MRSA) is one of the leading nosocomial 
pathogen that is also emerging as a zoonotic pathogen. In this review, it was observed that rapid 
emergence of new MRSA clones at a higher frequency has ushered in a new knowledge on the clonality 
and epidemic potentials of MRSA. Secondly, the success of treatment and management of MRSA 
infection is threatened by the diversity in the clonal types. This is because different clones harbours 
different antibiotics resistance characteristics and as such respond differently to treatment. Furthermore, 
clonal replacement of hospital-acquired MRSA with community -acquired MRSA has also been 
observed. Thirdly, the transmission of MRSA even though previously thought to be exclusively within 
the hospital setting through hand contact and nasal colonization has now spread to the community and in 
addition human to animal and animal to human transmission has also been observed.  Similarly, pet 
owners, veterinarians and farmers have been described as high-risked group with potentials of becoming 
reservoirs of MRSA. Furthermore, the adoption of hand hygiene in healthcare setting have to a great 
extent reduced the incidence of MRSA in the hospital. And lastly, the advent of molecular typing such as 
Pulsed Field Gel Electrophoresis (PFGE), Multi Locus Sequence Typing (MLST), Staphylococcal protein 
A typing (Spa typing) and Double Locus Sequence Typing (DLST) have proven to be a useful tool in 
providing valuable information on the evolution and clonal diversity of MRSA.  These in turn help 
researchers to answer some pertinent questions on the epidemiology of MRSA.  
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Introduction  
The evolution and worldwide spread of Staphylococcus aureus causing nosocomial and community 
acquired infections is of immense veterinary and public health importance (Ghaznavi-Rad et al., 2010). 
Staphylococcus aureus is the most clinically important and well-studied human pathogen causing 
nosocomial, community and livestock acquired infections worldwide (Basset et al., 2011).The spectrum 
of disease  caused by these pathogen in humans range from mild uncomplicated  superficial skin abscess 
to a more life threatening infections such as endocarditis, chronic pneumonia, nervous diseases and 
toxaemia  (Grema et al., 2015) whereas in animals, it  causes  mastitis in cows, septicaemia and arthritis 
in chickens, pyaemic dermatitis in dogs and botryomycosis in horses (Zunita, Bashir, & Hafizal, 2008). 
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Methicillin resistant S. aureus (MRSA) was first isolated in United Kingdom in the early 1960s when a 
strain of S. aureus developed resistance to a semi-synthetic beta lactams antibiotics a few months after it 
was introduced for the treatment of S. aureus infections (Chambers, 1997; Chen et al., 2014). 
Development of resistance to methicillin occurs as a result of the acquisition of a genomic island carrying 
methicillin resistance determinant mecA that codes for an alternative penicillin binding protein (PBP2’) 
with reduced susceptibility to methicillin (Leonard & Markey, 2008). Penicillin binding protein functions 
in sustained crosslinking of the peptidoglycan layer of the cell wall when methicillin inhibits the 
penicillin binding protein normally associated with cell wall development (Noto, Fox, Paige & Archer, 
2008).  
 
Since then, these early MRSA clones termed the “archaic clone”, were isolated in many countries across 
Europe, until the early 1970s when a new epidemic clone was identified in the United States, Australia 
and Ireland (Chen et al., 2014). In the United Kingdom, seventeen epidemic MRSA strains were 
identified with EMRSA-15 and EMRSA-16 being the most predominant and a major cause of nosocomial 
infection in countries across Europe and America (Grema, Geidam, Gadzama, Ameh, & Suleiman, 2015). 
However, researchers have observed that it actually originated from Africa where it has been associated 
with both nosocomial and community associated MRSA infections in Algeria (Grema et al., 2015). To 
date, five major pandemic clones have so far been identified. These include the Brazilian or ST239-IIIA 
clone, the Iberian clone or ST 247-IA clone, the New York/Japanese or ST-II clone, the paediatric or ST-
IV clone and the Hungarian clone or ST 239III (Basset et al., 2011; Blanc et al., 2007; Neela et al., 2010). 
Other clones identified, include EMRSA-15, EMRSA-16 and the Berlin clone which are found in 
Northern Europe. In Asia, Ghaznavi-Rad et al. (2012) reported the identification of about six major clonal 
complexes (ST-239-CC8, ST-1-CC1, ST188-CC1, ST-22-CC22, ST-7-CC7 and ST-1283-CC80).  
 
Until early 2000, MRSA was believed to be exclusively a healthcare problem, causing infection among 
individuals with identifiable risk factors associated with  nosocomial infection; however, MRSA strains  
infecting  healthy individuals in the community with no  apparent identifiable  risk factors  associated 
with  hospital acquired MRSA were observed  in a local  population in Australia and later in cases of 
severe infection  in children in the US ,and  this new clone is termed CA-MRSA (David & Daum, 2010; 
Rasigade & Vandenesch, 2014; Witte, 2009). Even though CA-MRSA strains are known to be resistant 
only to beta lactams antibiotics and causes infection only among healthy individuals living in the 
community, a new form of CA-MRSA with multiple drug resistance causing infection in hospital setting 
have been reported (Chen et al., 2014; Witte, 2009). For example, the USA clone (USA300) known to be 
initially causing infection in the community, is now being isolated in health care setting (Basset et al., 
2011; Witte, 2009) However, it could be due to strain replacement as observed in other geographical 
locations.  In Malaysia and other Asian countries, ST 239 is reported as the most predominant clone. This 
clone was first reported in Brazil in 1995 and later in 1997 in Hungary, and surprisingly from 1998-2003 
it disappeared from the Hungarian institution and was replaced by sequence type ST 228-I and ST 5-II 
(Lencastre et al., 1997; Neela et al., 2010). ST 239 was also identified in Africa, and the Middle East 
(Grema et al., 2015). Recently, MRSA strain causing infections in livestock, pets and companion animals 
have also been reported (Fitzgerald, 2012; Graveland, Duim, Van Duijkeren, Heederik, & Wagenaar, 
2011; Larsen et al., 2012). This new strain of MRSA was first associated with human disease in 2003,but 
was  actually isolated from  animals in 1970s (Graveland et al., 2011; Larsen et al., 2012; Saleha & 
Zunita, 2010; van Cleef et al., 2011) when a clone of MRSA associated with a reservoir in pigs and cattle  
were isolated in humans.   
 
These scenarios were created as a result of the frequent change in the epidemiology of MRSA which have 
been observed to have serious clinical implication.  In addition, the epidemiology of MRSA revealed by 
molecular typing techniques showed that emerging clones were observed to harbour different resistance 
and virulence marker from the already existing clones (Kuhn, Francioli, & Blanc, 2006; Enright et al., 
2000).  The sudden drift in the epidemiology of MRSA  infections over the past five decades, coupled 
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with its emergence as a potential zoonosis have been observed  to have occurred due to expansion and 
replacement of the already existing clones. In addition, studies have shown that higher frequency rate of 
MRSA within a particular geographical area is a reflection of successful spread of one or several clones 
and this varies depending on the health-care setting, country or region (Basset et al., 2011). Furthermore, 
it has also been observed that even within a particular region, variation is observed within clones; with 
some increasing in number while some fading away (Blanc et al., 2007). This   review focuses on the 
importance of molecular epidemiology as a valuable tool in determining the emergence and clonal 
distribution of MRSA with the intent of providing useful epidemiological data necessary for the 
prevention and control of MRSA.  
  
Mode of Transmission 
Methicillin- resistant Staphylococcus aureus also known as the “superbug”, and  multi-drug resistant S. 
aureus is one of the most significant pathogen resistant to almost all beta lactams antibiotics (Lindsay & 
Holden, 2006).Transmission was previously thought to be exclusively hospital-associated through hand 
contact and nasal colonization, but studies have identified individuals without the identifiable risk factors 
of  prior contact with hospital, antibiotics use, use of invasive surgical devices as well as chronic disease 
coming down with the disease as a result of community associated MRSA (Chuang & Huang, 2013). 
Both community-associated and hospital-associated MRSA share some level of similarities; however, 
they differed in their virulence and antibiotic resistance capabilities (Appelbaum, 2007). Individuals at 
risk of CA-MRSA infection include prisoners, soldiers, and children living in and overcrowded 
environment, injection drug users, and men who sleep with fellow men (Charlebois et al., 2004).  
 
In the hospital, MRSA contamination is spread through either contact with infected patients or through 
aerosols. Areas normally contaminated include, clothing, beddings, furniture, medical instruments, 
toiletries and contaminated surfaces like door handles, tables, chairs and walls (Grema et al., 2015).  In a 
study to determine the prenatal infant maternal transmission of MRSA, it was observed that 43 of the 304 
mothers sampled were colonized by S. aureus whereas nine among the 43 colonised women had MRSA. 
Similarly 25 out of 252 infants sampled were colonized by S. aureus while nine had MRSA. Furthermore, 
DNA finger printing also revealed five isolates from mother and infant pair had similar PFGE pattern 
indicating the possibility of mother to infant transmission (Pinter, Mandel, Hulten, Minkoff, & Tosi, 
2009). In another study demonstrating MRSA transmission in infants from two frequently MRSA 
colonised nurses in a maternity clinic, genotypic analysis RFLP from PFGE revealed that the persistently 
colonised nurses had genotypically identical MRSA as those isolated from their children. In addition, 
nasal decolonization of the nurses also results in decline in MRSA carriage rates among infants in the 
paediatric unit (Mitsuda et al., 1999).  
 
MRSA was rarely isolated from animals, until recently when high level outbreaks were reported in 
livestock animals such as pigs, chickens, and cows and which were believed to act as potential reservoirs 
of MRSA infections to humans (Dressler et al., 2012; Fitzgerald, 2012). A case of bidirectional 
transmission between animals and humans was also reported (Saleha & Zunita, 2010) indicating the 
possibility of MRSA being a potential zoonosis. Dressler et al. (2012) also reported that livestock 
workers, veterinarians, people attending animal exhibition and children as high risk group for 
colonization with MRSA. Colonization of dogs and cats by S. aureus does not normally occur, although 
transitory association is observed and can sometimes cause very serious infections. There is however, 
similarities in the genotypes of MRSA isolated from pets and those isolated from humans which are 
endemic in certain parts of the world such as ST5 in the United States. Not much clinical significance is 
attached to MRSA colonization in companion animals, however there are some speculations that they can 
serve as potential reservoirs of infection for humans in contact with them (Fitzgerald, 2012). 
 
Several studies have reported the occurrence of animal to humans MRSA transmission and vice-versa. 
Weese et al. (2006) described a suspected case of MRSA transmission between household pets to humans 
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and humans to household pets when one of the eight MRSA isolated from pets were indistinguishable 
with the human isolates. Similarly, elimination of MRSA colonization in two individuals was achieved 
only after nasal decolonization of their dog; thus indicating that the dog served as a reservoir for MRSA 
(Weese et al., 2006).Furthermore, in the Netherlands and Belgium colonization of dog and black rats have 
been reported as a source MRSA infection (van Duijkeren et al., 2004; Van de Giessen et al., 2009).  
 
Evolution and Clonal Spread  
The rapid emergence of new clones of MRSA on a frequent basis has ushered in a new knowledge on the 
clonality and epidemic potentials of MRSA. The successful treatment and management of MRSA 
infection is threatened by the diversity in the clonal types; this is because different clones have different 
antibiotics resistance characteristics and as such differ in their response to treatment (Ghaznavi-Rad et al., 
2012).  In addition, the changing epidemiology and worldwide spread of MRSA over the past decades 
have constitute a major challenge to effective treatment and management of MRSA infection. This is due 
largely to the rapid rate of acquisition of resistance determinants to methicillin and other classes of 
antibiotics (Neela et al., 2010). 
 
 During the early 1960s, MRSA was isolated in many countries including Europe and America; however, 
the incidence was low and only isolated cases were reported. It was not until the 1980s when a change in 
the prevalence and steady increase were observed worldwide with many epidemic strains causing 
hospital-associated MRSA infection (Hryniewicz, 1999). For instance, the stock cultures isolated from a 
case of bacteraemia   in the 1950s in Denmark gave a new insight into the origin and evolution of MRSA 
from MSSA. It was revealed that most MRSA and MSSA isolates belong to the same phage group III 
(Lindsay & Holden, 2006; Oliveira & de Lencastre, 2002). Furthermore, Stewart & Holt (1963) revealed 
that the first European MRSA isolate resistant to streptomycin, penicillin, tetracycline and sometimes 
erythromycin identified in the United Kingdom also belongs to the phage group III. This dynamic change 
observed in the epidemiology of MRSA was attributed to sustained and indiscriminate use of antibiotics 
for agricultural use, veterinary and treatment of human infections, mutation, acquisition of antibiotics 
resistance determinants and lack of proper approach to prevention and control of MRSA spread (Grema et 
al., 2015; Hryniewicz, 1999).  
 
Molecular genetic information also revealed that the early Denmark and UK isolate also belong to the 
same clone, both having methicillin resistance determinant mecA and deficient in regulatory gene mecI 
and transposon Tn554. The recovery of these strains in more than 18 hospitals across Denmark also 
validates their epidemic potentials (Ito, Okuma, Ma, Yuzawa, & Hiramatsu, 2003). These findings further 
buttress our knowledge with regard to the first S. aureus progeny that receives heterologous methicillin 
resistance determinants horizontally from a known donor, a scenario that led to the emergence of MRSA. 
Furthermore, molecular typing reveals a similarity in genetic make- up between the early MRSA isolates 
and the widely disseminated multi drug resistant Iberian clone; however, unlike the early “archaic” clone, 
the Iberian clone carries other plasmids and transposon-borne resistant determinants (De Lencastre, 
Chung, & Westh, 2000; Katayama, Ito, & Hiramatsu, 2000). In addition, the use of molecular typing 
techniques from 1994 to 2000 has helped in clonal discrimination and distribution of MRSA isolates 
across different continents (Tomasz & De Lencastre, 1997).This was depicted in the distribution of the 
five identified pandemic clones throughout the globe. The Iberian clone was first isolated in Spain in 
1989 and was later isolated in Italy, Germany, Switzerland, the United Kingdom, Portugal, Belgium, 
Czech republic, France and the United States of America, whereas the Brazilian clone which was initially 
isolated in Brazil in 1992 was later found to be replacing isolates in Portugal, Chile, Argentina, Uruguay 
and Czech republic. However, the Hungarian clone was only widely disseminated in major hospitals 
across Hungry and Taiwan, while the New York/Japan clone was   found dominating hospitals across 
New York, Pennsylvania, New Jersey, Connecticut and Japan, and lastly, the paediatric clone which was 
first isolated in Portugal at the paediatric hospital in 1992 was later isolated in Argentina, United states, 
Columbia and Poland (Oliveira & de Lencastre, 2000).  Furthermore,  MLST and Staphylococcus 
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Cassette Chromosome (SCCmec) typing of MRSA strains from 12 different Asian countries revealed 
clonal complex CC5-II  as the most predominant clones in Korea and Japan while ST 239 appearing as 
the dominant clones in remaining Asian countries sampled(Chuang & Huang, 2013; Neela et al., 2010). 
This difference in strain types found in different countries is due to the difference in risk factors 
associated with infection, clone replacement, horizontal transfer of resistance and virulence determinants, 
mutation and cross-border migration (Chua et al., 2014). 
 
Molecular Typing Methods of MRSA 
Molecular typing techniques have greatly facilitated the epidemiological surveillance of MRSA and 
effective evaluation of prevention and control of infection as well as antibiotic prescribing measures 
(Murchan et al., 2003). Depending on the method adopted, (PFGE, MLST and Protein A typing Spa-
typing), molecular typing techniques normally have helped researchers to group MRSA into clones 
(Basset et al., 2011). Thus far, MLST has been described as the most robust subtyping system for S. 
aureus and MRSA. These techniques vary in discriminatory power, reproducibility, usage and cost and 
only give approximation of the strain genome (Chua, Howden, Jiang, Stinear, & Peleg, 2014).  
 
Pulsed-Field Gel Electrophoresis (PFGE) 
This is the commonest typing method for the analysis of S. aureus and MRSA epidemiology and is 
regarded as the “gold standard” or method of choice because of its’ high discriminatory power (Basset et 
al., 2011; Chua et al., 2014; Cookson et al., 2007).    Digestion of bacterial genomic DNA with SmaI 
restriction enzymes within an agarose plug and electrophoresis to resolve them gives a banding pattern of 
8 to 20 bands which can be used to compare with PFGE profiles of other S. aureus isolates. PFGE is 
reproducible and allows for separation of larger fragments of genomic DNA. In addition, it can also detect 
acquisition or loss of mobile genetic elements and introduction and removal of restriction sites due to 
mutation or gene deletion (Basset et al., 2011; Blanc et al., 2007; Chua et al., 2014) and also allows for 
monitoring of MRSA transmission and has the ability to detect MRSA clones with potentials of causing 
outbreaks at a local and international level (Enright et al., 2000). This technique does not allow for inter-
laboratory comparison of MRSA strains and data can be ambiguous, so it cannot be use to study 
epidemiology of MRSA at global level. However, this technique is still being used by the Centre for 
Disease Control and Prevention (CDC) in defining MRSA strains in the United States (Chua et al., 2014). 
Other limitations of PFGE for S. aureus typing  are that the nature of interpretive criteria is arbitrary, 
might not  be too discriminatory for local or short-term epidemiological studies and the analysis of band 
pattern is subjective (Cookson et al., 2007). 
 
Multilocus sequence typing (MLST) 
MLST is a highly discriminatory and widely accepted technique for typing of S. aureus and MRSA 
epidemiology on the basis of sequence of 450bp internal fragment of the seven house-keeping genes and 
it is basically a sequenced based interpretation of the multilocus enzyme electrophoresis (MLEE) (Chua 
et al., 2014; Enright et al., 2000; Kuhn et al,. 2006). The technique is designed to evaluate and compare 
genetic polymorphism in a group of bacterial pathogens worldwide. Isolates are defined by distinct alleles 
assigned for the sequence of each house-keeping gene loci. Since there is more than one allele in each of 
the sequence of the seven house-keeping genes, the probability of having a sequence with a similar allele 
by chance is highly unlikely (Enright et al., 2000). MLST provides important information about the 
variation in the nucleotide sequence of the bacterial core genome, the evolutionary origin of a clone, the 
phylogenetic relatedness between among strains and recombination rate (Basset et al., 2011). The merit of 
this technique is that it is reproducible among laboratories, can be used for intercontinental comparison of 
strains and the data is unambiguous. The main disadvantage however, includes cost and relatively low 
discriminatory power when use for local epidemiological studies (Basset et al., 2011; Enright et al., 
2000). 
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 Staphylococcal protein A(Spa)-typing 
This is another widely used sequenced based typing method that employs the use of highly discriminatory 
genetic marker to characterize bacterial pathogen allowing the identification of closely related isolates 
with common ancestral origin (Chau et al., 2014; Grundmann et al., 2010). The spa-typing codes for 
protein A is a specie specific gene known for binding capacity for immunoglobulin G (IgG) (Basset et al., 
2011; Grundmann et al., 2010). These loci have a high level polymorphism due to a variation in the 
internal region of short tandem repeats, which  vary in numbers and substitution within individual repeat 
unit (Basset et al., 2011), a succession of number corresponding to each individual repeat unit of the X 
region represents the spa profile (Kuhn et al., 2007). This technique provides portable data that are 
unambiguous and biologically meaningful with great utility for epidemiological studies such as in 
transmission and outbreak investigation of S. aureus infection different within geographical location 
(Grundmann et al., 2010). However, Spa typing might reflect homoplasy, the analysis complicated and its 
discriminatory power lower than PFGE (Basset et al., 2011; Kuhn et al., 2007). 
 
Double Locus Sequence Typing (DLST) 
Recently, a new molecular typing method based on the analysis of partial sequences (ca. 500 bp) of the 
highly variable clumping factor B (clfB) and spa genes called   Double Locus Sequence Typing (DLST) 
was developed (Basset et al., 2011). High discriminatory power ability more than the traditional spa and 
PFGE have been observed with this method (Kuhn et al., 2007);  furthermore, high level of type ability, 
reproducibility, ease of use, low cost and unambiguous level of type definition makes this technique a 
promising method for epidemiological studies of MRSA. This method is limited by the fact the spa alleles 
determined by two methods are not identical; this is because DLST analyses the same region of gene. 
 
Clonal Distribution in Human  
In recent years, we have witnessed an increase in the emergence of new and highly pathogenic strains of 
bacteria that are resistant to almost all known antibiotics with high therapeutic effect. Thus, this lead to 
increase in health-care cost and prolonged hospital stay, especially in countries where there is poor 
legislation with regard to the use of antibiotics in the treatment of human infection and in agriculture. 
 
Methicillin Resistant Staphylococcus aureus (MRSA) is a significant problem in health care hospitals and 
is now commonly recovered in virtually every large hospital in the United States (Musser & Kapur, 
1992). This was demonstrated in the work of Zahar & Timsit (2007)  where an  increase in MRSA 
infection rate in the intensive care unit from 35.9% to 64.4% was observed between 1992- 2003. In 
Europe, however, the overall prevalence increased from 16% in 1999 to 24% in 2004 which was slightly 
lower than that of the United States.  In 2007, the European Union Surveillance network involving 13 
European countries reported that 6.2% of the 54,574 patients admitted in the intensive care unit (ICU) for 
a period of two days had acquired pneumonia. Furthermore, it was also revealed that the 17% of all ICU 
cases were caused by S. aureus and 33% of which were MRSA (Kock et al., 2010). In France, Group 
(1999) reported that 3.7% of patients in intensive care unit had at least one positive MRSA sample in a 
survey involving 43 hospitals.  Similarly, in a survey of 25 university hospitals across 15 European 
countries, Fluit et al. (2001) revealed that the prevalence of MRSA was high in southern  than in northern 
Europe where the authors observed a higher  prevalence of MRSA, 54% in Portugal, 43-58% in Italy 
while only 2% prevalence was observed in Switzerland and Netherlands.    
 
Recently, MRSA infection have been on the increase in United States, Europe and other parts of the 
world with 60% of all S. aureus infection in the ICU in United States were MRSA  (Boucher & Corey, 
2008). According to the 2008 report of the European Antimicrobial Resistance Surveillance system 
(EARSS), the prevalence of MRSA blood cultures in the Scandinavian countries was 5% whereas a 
prevalence of less than 10% was reported in Austria, Slovenia and Luxembourg and 10-24%  in Czech 
Republic, France, Belgium, Latvia, Hungry, Poland, Germany and Switzerland.  However, the prevalence 
was high (about 25% and above) in Israel, Portugal, Malta, Romania, Spain, Greece, Croatia, Cyprus, 
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Bulgaria, Italy, Turkey, Republic of Ireland and the United Kingdom (Kock et al., 2010). The incidence 
of MRSA was observed to be influenced by geographic location with more outbreaks recorded in the 
southern part of United States; similar scenario was observed in Europe where incidence of MRSA was 
0.5% in Iceland and 44% in Greece from 1999 to 2000 (Boucher & Corey,2008). Similarly, Grema et al., 
(2015) in their review also reported a greater than 50% of MRSA rate in the United State, Asia and Malta, 
25-50% in Africa, Europe and China while a relatively lower percentage in Europe; however, this result is 
dependent upon the sample size and area studied.  
 
Molecular typing techniques such as MLST, Spa typing and PFGE have revealed a high level of clonality 
among the S. aureus population with  more than ten major clonal complexes and abundant  minor lineage 
(CCs) CC1, CC5, CC8, CC22,CC30, ST239 and CC45 (Enright et al., 2000; Grema et al., 2015; Purrello 
et al., 2014).Clonal complexes CC5, CC8, CC22, CC30,ST239 and CC45 lineages, are the sources of 
hospital associated MRSA with each sequence type having a specific geographical distribution. While the 
community associated clones arose from clonal complexes (CC) CC1, CC8, CC30, CC59 and CC80 with 
increasing evidence of its being implicated in nosocomial infections recently in the United States (Basset 
et al., 2011; Grundmann et al., 2010; Purrello et al., 2014).  
 
The classical example of CA-MRSA clone is the ST-80 SCCmecIV associated with causing infection 
across Europe in low income earning group (Basset et al., 2011); others include CA-MRSA  
ST1(USA400) and ST8(USA300) which were reported as dominant clones in the United States. In Asian 
and the Pacific, the most dominant prevalent clone is the ST59 while ST30 is found almost all over the 
world (Chuang & Huang, 2013; Grema et al., 2015). CA-MRSA infected cases have been observed to 
spread across different continents such as Europe, South America, Asia, Africa and Middle East 
indicating the evidence of transboundary transmission of CA-MRSA (Grema et al., 2015). It is important 
to also note that, in areas where the prevalence of HA-MRSA is low, studies have shown that it has been 
replaced by CA-MRSA. The reason for the dominance of a clone in a particular area is poorly understood; 
however, studies have shown that CA-MRSA carries a small SCCmec type (V and IV) compared to HA-
MRSA and does not confer multiple resistance to antibiotics as well as result in a small fitness cost 
(Basset et al., 2011; Grema et al., 2015; Skov et al., 2006).   
 
The proportion of S. aureus strains resistant to methicillin causing infections in the community varies 
across different countries of the globe. Skov et al. (2012), in their review on CA-MRSA revealed that the 
CA-MRSA carriage rate worldwide ranges from less than 1% in some regions while greater than 50% in 
other regions; in addition,  they also observed that  CA-MRSA carriage rate was higher in young children 
than in adults; this could probably be due to lifestyle and  reduced immune response. In Europe, the 
overall prevalence of CA-MRSA is 1% and 2% in Germany and Spain respectively, 29-50% in Sweden 
and Denmark, while about 6% in outpatients in Italy, 30% in Greece, 14% in Germany and 18% in France 
(Kock et al., 2010) while in Asian countries, the incidence of CA-MRSA is between 2.5%-39% which is 
much lower than the USA300 clone isolated among individuals in the community in the United States 
(Chuang & Haung, 2013). 
  
Outbreaks of CA-MRSA infected cases were less in some countries while endemic in others. For 
instance, higher carriage rate of CA-MRSA infected cases were reported in the United States, Taiwan, 
Australia and Canada. However, in Taiwan alone from 1999 to 2005 there was a significant increase of 
CA-MRSA carriage rate in children from 9.8% to 56% (Chuang & Huang, 2013; Skov et al., 2012). In 
Europe, carriage of CA-MRSA infected cases were low compared to the United States and other regions 
across the globe; however, a significant increase in CA-MRSA was observed in the Netherlands, 
Denmark and France and even more prevalent and replacing HA-MRSA in Greece (Basset et al., 2011; 
Chuang & Huang, 2013; Skov et al., 2012). In a study involving 17 hospitals across eight Asian countries 
it was observed that the prevalence of CA-MRSA varied which could be due to the difference in study 
design, geographic location and MRSA control programme. The proportion of MRSA in the community 
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ranges between 2.5% to 39% with four countries (Taiwan, Vietnam, Sri Lanka and Philippines) having 
CA-MRSA prevalence of greater than 30% (Chuang & Huang, 2013). Similarly, in a review by Grema et 
al. (2015) high  prevalence of MRSA were  reported in South Korea (77.6%), Vietnam (74.1%),Taiwan 
(65%) and Hong Kong (56.8%) with CC8 (ST239-III) as the dominant strain causing infection in the 
hospital setting. 
 
In Malaysia, Ghaznavi et al. (2010) reported a prevalence of 21% upon reviewing results of microbiology 
laboratories in all the State hospitals. In another study, Choi et al. (2006) reported a 23.4% prevalence of 
MRSA after sampling 346 nasal swabs. Similarly, Al-Talib et al. (2013) also reported a 28.7% prevalence 
of MRSA when they assessed the burden of nasal MRSA among patients and health-care workers in 
Malaysia. According to the Report of the National Surveillance of Antibiotic Resistance (NSAR) in 
Malaysia, a total of 37, 341 S. aureus were isolated which was more than the number of S. aureus (34, 
492) isolated in 2013; however, about 18% of the S. aureus isolates were from blood samples. 
Furthermore, the overall numbers of MRSA isolates were almost similar with about 17.2% of the 36,064 
S. aureus isolates tested in 2014 and 17.7% out of 31,030 S. aureus isolates tested in 2013 (Norazah, 
2014).  
 
Clonal Distribution in Animals  
Evidence of isolation of MRSA in animals dates back to the early 1970s even though association with 
disease in humans was first reported in 2003 (Bosch et al., 2015). The rare isolation of MRSA in animals 
during this period from 1970 to early 2000 portrayed MRSA as exclusively a human problem (Graveland 
et al., 2011) until 2007, when  transmission of MRSA from cows to humans was reported. In addition, a 
case of livestock-associated MRSA was reported in a 6 month old girl following invasive surgery in a 
hospital in the Netherlands even after several decolonization procedures (Voss, Loeffen, Bakker, 
Klaassen, & Wulf, 2005). Molecular typing shows that the livestock-associated MRSA was non typable 
by PFGE using Sma1 restriction enzymes and belongs to clonal complex CC398 (Graveland et al., 2011). 
Isolation of MRSA in pets, companion animals, chickens, and cattle have been reported (Saleha & Zunita, 
2010). However, molecular studies have shown that these strains are similar to the strains isolated in 
humans indicating transmission from humans to animals (Grema et al., 2014). In the Netherlands, about 
40% of the MRSA isolated in humans were livestock associated (Bosch et al., 2015). Furthermore, 
Leonard & Markey (2008) revealed that 14% of the   65 patient attending seven different veterinary 
teaching hospitals were infected with MRSA and that the MRSA colonization was common in canine and 
equine, indicating the possibility that dogs, cats and horses can serve as a reservoir for zoonotic 
staphylococcal infection as reported by Mann in 1959. In another study using specimens from cattle, pigs, 
and chickens. Lee, (2003) found that, of the 421 S. aureus isolated collected 15 (3.6%) were resistant to 
oxacillin and positive for mecA.  The prevalence of MRSA in China, Japan, Taiwan and South Korea 
ranges between 70%-80% (Chuang & Huang, 2013). In Korea, Lim et al. (2012) carried out a study in 
pigs from February 2008 to May 2009 and reported a prevalence of MRSA in pigs at 3.2% and 22.7% 
respectively. The authors also reported two types of MRSA strain  amongst the population of the MRSA 
isolates that were studied, with  17 strains being  livestock-associated type (LA; ST398) and 4 strains 
being human-associated type (HA; ST72). The most prevalent type strain being ST398 (57%), followed 
by ST541 (23.8%) and the rest of the isolates were ST72, thus, indicating the existence of not only 
livestock -associated types (ST398 and ST541) but also human- associated type (ST72) MRSA in pigs. 
  
In Malaysia, studies carried out   among pigs and pig handlers by Neela et al. (2009) in 360 pigs and 90 
pig handlers from 30 farms identified novel ST9 spa type t4358- V MRSA strains that were found to 
transiently colonize more than 1% of pigs and 5.5% of pig handlers. In another studies however, Neela et 
al. (2010) reported the prevalence of another MRSA strain of pig origin with Spa sequencing and MLST 
and documented t037 and ST 239 (CC8) in 83.3% of the isolates.  
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MRSA as emerging zoonosis 
In the past decades, major changes were seen to have occurred in the epidemiological traits, resistance 
development, host and environmental interaction of MRSA. Until recently, infection with MRSA was 
initially thought to be restricted to hospital setting. However, the emergence of a new strain of MRSA 
with a characteristically unique epidemiology, microbial and clinical identity to the hospital associated 
was reported (van Cleef et al., 2011). In addition, recent findings also indicate a link between MRSA 
carriage in livestock and infection in individuals who have close contact with animals (Springer et al., 
2009). Furthermore, Petersen et al. (2013) reported that inter-specie transmission of MRSA between 
human and animal reservoirs may have been achieved by host adaptation as well as to selective pressure 
to antibiotics. Similarly, isolations of MRSA have been  reported in a variety of domestic animals  such as 
cats, dogs pigs, sheep, chickens and horses leading to a sudden increase in reports and interest in 
colonization and infection with MRSA and infection in animals (Leonard & Markey, 2008;  Saleha & 
Zunita, 2010). Luzzago et al. (2014) reported that t1328 and ST22 isolates obtained from the liver of the 
chamois kid were methicillin-resistant S. aureus (MRSA) harbouring SCCmec cassette type IV. 
Furthermore, Price et al. (2012) reported that MRSA ST398 initially originated as methicillin susceptible 
S. aureus in a human, which was later transmitted to pigs and in which it acquires methicillin resistance, 
and is now seen re-infecting humans. In 2011, Petersen et al, (2013) reported the isolation of S. aureus in 
cattle and humans with a new homologue of SCCmec designed as SCCmecC.  
 
Individuals in frequent contacts with farm animals and household pets as well as veterinarians have been 
described as high risk with potentials of becoming reservoirs of MRSA (Weese et al., 2006). In addition, 
evidence of transmission of MRSA from pet owners to their pets and subsequent re-infection has been 
reported to have occurred (Weese et al., 2006). In a study carried out in two veterinary hospitals in the 
United States and Canada, O’Mahony et al. (2005) reported  veterinary staff as the primary source of 
MRSA infection however the mechanism of which is unknown, while the report from Canada suggested 
environmental contamination as the main culprit, in particular contamination of stalls housing MRSA 
positive animals. Studies on livestock-associated MRSA as a cause of infection and colonization of 
humans by the network of the Dutch German project revealed that although the predominant clone 
associated with LA-MRSA is the CC 398, the other clonal complexes such as CC5, CC9 and CC97 were 
also detected in livestock animals. Furthermore, the joint project also revealed that of the 14,036 MRSA 
isolates obtained between January 2008 to June 2012 from human clinical and screening specimens in an 
area of high density livestock production, Protein A sequence analysis revealed that 578 staphylococcal 
protein A Spa types LA-MRSA were among the human isolates which accounted for about 18.6% of all 
the human isolates. 
 
Prevention and Control 
Methicillin resistant S. aureus strain is a significant health care problem, resulting in prolonged hospital 
stay, reduction in the therapeutic value of antibiotics and treatment cost. The reduction and low level 
maintenance in the incidence of HA-MRSA blood stream infection in many countries across the world 
has yielded much positive result. The success achieved in these countries is as a result of the 
implementation of a holistic approach involving the combination of several preventive interventions 
which include but not restricted to decolonization, screening, prevention of contact, appropriate 
prescription and use of antibiotics and many other important preventive measures (Kock et al., 2010).  
 
The adoptions of hand hygiene in healthcare setting have been demonstrated to play a crucial role in 
reducing the incidence of MRSA in the hospital (Allegranzi & Pittet, 2009; Pittet et al., 2006). McBryde 
et al. (2004) in their studies demonstrated that  17%  of contact between a patient colonised with MRSA 
and a health care worker led to the transmission of MRSA from patients to the gloves of health care 
worker; thus, further buttressing our understanding on the importance of hand hygiene in the prevention 
and control of MRSA spread. The adoption of these measures in some European countries has led to the 
reduction of S. aureus and MRSA blood stream infection to the  minimum, for instance between 2004 and 
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2008 in Belgium, a sufficient reduction in the mean incidence of  nosocomial associated MRSA from 30 
to 25% was observed, whereas in France the adoption of a 16years national nosocomial infection control 
programme led to 30% decrease of surgical site infection and 20% reduction in MRSA carriage rates in 
blood cultures (Kock et al., 2010). Similarly in the UK, the adoption of guidelines for the prevention of 
MRSA in health care institution between 2004 and 2008 led to halving the incidence of MRSA blood 
stream infection. The intervention measures adopted include, systematic surveillance, appropriate 
prescription of antibiotics, screening of MRSA infected patients, nasal decolonization and other valuable 
measures necessary for the reduction of MRSA spread (Coia et al., 2006). 
 
Conclusion and Recommendation 
The evolution and worldwide spread of MRSA is a major public health challenge, especially with the 
emergence of community and livestock- acquired MRSA. The emergence of several pandemic clones 
coupled with rapid changes observed in their epidemiology on a major scale have important clinical 
implication on the patient, health care workers and pharmaceutical companies. This is because new clones 
harbours different determinants for virulence and antibiotic resistance. Furthermore, the advent of 
molecular typing technologies have proven to be useful in providing valuable insight on the evolution and 
clonality of MRSA; this in turn help in providing useful information regarding the epidemiology of 
MRSA. Understanding the factors influencing the emergence and spread of MRSA will help in providing 
the impetus towards designing an effective model that will help in prevention and control of MRSA 
infection. This review explore the significance of molecular epidemiology as a valuable tool in 
determining the emergence and clonal diversity of MRSA. It is therefore recommended that a standard 
molecular typing protocol be developed to help ensure harmony in strain typing techniques at regional or 
global level.  
 
Acknowledgements: This scholarly research review has been supported by Universiti Putra Malaysia 
Research University Grant (9428800) and Fundamental Research Grant Scheme, Ministry of Higher 
Education Malaysia (5524643).  
 
Author’s contribution: The design and execution of this research study is a collective effort of all the 
authors. All authors were also involved in the critical analysis and review of the draft manuscript. There is 
no conflicting interest. 
 
References 
Allegranzi, B., & Pittet, D. (2009). Role of hand hygiene in healthcare-associated infection prevention. 
Journal of Hospital Infection, 73(4), 305-315.  
Al-Talib, H., Yean, C.Y., Hasan, H., Nik Zuraina, N.M., & Ravichandran, M. (2013). Methicillin-
resistant Staphylococcus aureus nasal carriage among patients and healthcare workers in a 
hospital in Kelantan, Malaysia. Polish Journal of Microbiology, 62(1), 109-112.  
Appelbaum, P .C. (2007). Microbiology of antibiotic resistance in Staphylococcus aureus. Clinical 
Infectious Diseases, 45(Supplement 3), S165-S170.  
Basset, P., Feil, E. J., Zanetti, G., & Blanc, D .S. (2011). 25 - The Evolution and Dynamics of Methicillin-
Resistant Staphylococcus aureus. In M. Tibayrenc (Ed.), Genetics and Evolution of Infectious 
Disease (pp. 669-688). London: Elsevier. 
Blanc, D. S., Petignat, C., Wenger, A., Kuhn, G., Vallet, Y., Fracheboud, D., Siegrist, H.H. (2007). 
Changing molecular epidemiology of methicillin-resistant Staphylococcus aureus in a small 
geographic area over an eight-year period. Journal of clinical microbiology, 45(11), 3729-3736.  
Bloemendaal, A.L.A., Brouwer, E.C, & Fluit, A. C. (2010). Methicillin resistance transfer from 
Staphylocccus epidermidis to methicillin-susceptible Staphylococcus aureus in a patient during 
antibiotic therapy. PLoS One, 5(7), e11841.  
Boerema, J.A., Clemens, R., & Brightwell, G. (2006). Evaluation of molecular methods to determine 
enterotoxigenic status and molecular genotype of bovine, ovine, human and food isolates of 
PJSRR (2016) 2(2): 121-134 
eISSN: 2462-2028  © Universiti Putra Malaysia Press 
 
131 
 
Staphylococcus aureus. International Journal of Food Microbiology, 107(2), 192-201. doi: 
http://dx.doi.org/10.1016/j.ijfoodmicro.2005.07.008 
Bosch, T., Verkade, E., van Luit, M., Landman, F., Kluytmans, J., & Schouls, L.M. (2015). Transmission 
and Persistence of Livestock-Associated Methicillin-resistant Staphylococcus aureus among 
Veterinarians and Their Household Members. Applied and environmental microbiology, 81(1), 
124-129.  
Boucher, H.W., & Corey, G.R. (2008). Epidemiology of methicillin-resistant Staphylococcus aureus. 
Clinical infectious diseases, 46(Supplement 5), S344-S349.  
Chambers, H.F. (1997). Methicillin resistance in staphylococci: molecular and biochemical basis and 
clinical implications. Clinical microbiology reviews, 10(4), 781-791.  
Charlebois, E.D., Perdreau-Remington, F., Kreiswirth, B., Bangsberg, D.R, Ciccarone, D., Diep, B.A., 
Chambers, H.F. (2004). Origins of community strains of methicillin-resistant Staphylococcus 
aureus. Clinical infectious diseases, 39(1), 47-54.  
Chen, C.J., Huang, Y.C, Su, L.H, Wu, T.L, Huang, S.H, Chien, C.C,  Ko, W.C. (2014). Molecular 
epidemiology and antimicrobial resistance of methicillin-resistant Staphylococcus aureus 
bloodstream isolates in Taiwan, 2010.  
Chiang, Y.C., Liao, W.W., Fan, C.M., Pai, W.Y., Chiou, C.S., & Tsen, H.Y. (2008). PCR detection of 
Staphylococcal enterotoxins (SEs) N, O, P, Q, R, U, and survey of SE types in Staphylococcus 
aureus isolates from food-poisoning cases in Taiwan. International Journal of Food 
Microbiology, 121(1), 66-73. doi: http://dx.doi.org/10.1016/j.ijfoodmicro.2007.10.005 
Choi, C.S., Yin, C.S., Bakar, A.A., Sakewi, Z., Naing, N.N., Jamal, F., & Othman, N. (2006). Nasal 
carriage of Staphylococcus aureus among healthy adults. Journal of microbiology, immunology, 
and infection Wei mian yu gan ran za zhi, 39(6), 458-464.  
Chua, K.Y.L., Howden, B.P., Jiang, J-H., Stinear, T., & Peleg, A.Y. (2014). Population genetics and the 
evolution of virulence in Staphylococcus aureus. Infection, Genetics and Evolution, 21(0), 554-
562. doi: http://dx.doi.org/10.1016/j.meegid.2013.04.026 
Chuang, Y.Y., & Huang, Y.C. (2013). Molecular epidemiology of community-associated meticillin-
resistant Staphylococcus aureus in Asia. The Lancet Infectious Diseases, 13(8), 698-708.  
Coia, J.E., Duckworth, G.J., Edwards, D.I., Farrington, M., Fry, C., Humphreys, H. (2006). 
Chemotherapy, Joint Working Party of the British Society of Antimicrobial. Guidelines for the 
control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare 
facilities. Journal of hospital infection, 63, S1-S44.  
Cookson, B.D., Robinson, D.A., Monk, A.B., Murchan, S., Deplano, A., De Ryck, R., Salmenlinna, S. 
(2007). Evaluation of molecular typing methods in characterizing a European collection of 
epidemic methicillin-resistant Staphylococcus aureus strains: the HARMONY collection. Journal 
of clinical microbiology, 45(6), 1830-1837.  
Cuny, C., Nathaus, R., Layer, F., Strommenger, B., Altmann, D., & Witte, W. Nasal colonization of 
humans with methicillin-resistant Staphylococcus aureus (MRSA) CC398 with and without 
exposure to pigs.  
David, M.Z., & Daum, R.S. (2010). Community-associated methicillin-resistant Staphylococcus aureus: 
epidemiology and clinical consequences of an emerging epidemic. Clinical microbiology reviews, 
23(3), 616-687.  
Davis, S.L., Perri, M.B., Donabedian, S.M., Manierski, C., Singh, A., Vager, D., Robinson-Dunn, B. 
(2007). Epidemiology and outcomes of community-associated methicillin-resistant 
Staphylococcus aureus infection. Journal of clinical microbiology, 45(6), 1705-1711.  
De Lencastre, H., Chung, M., & Westh, H. (2000). Archaic strains of methicillin-resistant Staphylococcus 
aureus: molecular and microbiological properties of isolates from the 1960s in Denmark. 
Microbial Drug Resistance, 6(1), 1-10.  
Diep, BA., Carleton, H.A., Chang, R.F., Sensabaugh, G.F., & Perdreau-Remington, F. (2006). Roles of 
34 virulence genes in the evolution of hospital-and community-associated strains of methicillin-
resistant Staphylococcus aureus. Journal of Infectious Diseases, 193(11), 1495-1503.  
PJSRR (2016) 2(2): 121-134 
eISSN: 2462-2028  © Universiti Putra Malaysia Press 
 
132 
 
Dressler, A.E., Scheibel, R.P., Wardyn, S., Harper, A.L., Hanson, B.M., Kroeger, J.S., Diekema, D.J., 
Bender, J.B., Gray, G.C. and Smith, T.C., (2012). Prevalence, antibiotic resistance and molecular 
characterisation of Staphylococcus aureus in pigs at agricultural fairs in the USA. Veterinary 
Record: Journal of the British Veterinary Association, 170(19).  
Enright, M.C., Day, N.P.J., Davies, C.E., Peacock, S.J., & Spratt, B.G. (2000). Multilocus sequence 
typing for characterization of methicillin-resistant and methicillin-susceptible clones of 
Staphylococcus aureus. Journal of clinical microbiology, 38(3), 1008-1015.  
Fitzgerald., J. R. (2012). Livestock-associated Staphylococcus aureus: origin, evolution and public health 
threat. Trends in Microbiology, 20(4), 192-198. doi: http://dx.doi.org/10.1016/j.tim.2012.01.006 
Fluit, A.C., Wielders, C.L.C., Verhoef, J., & Schmitz, F-J. (2001). Epidemiology and susceptibility of 
3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European 
SENTRY study. Journal of clinical microbiology, 39(10), 3727-3732.  
Ghaznavi-Rad, E., Neela, V., Shamsudin, M.N., Moghaddam, H.G., Tavakol, M., van Belkum, A., 
Andar-Ali, A.F. (2012). Diversity in the antimicrobial susceptibility patterns of methicillin-
resistant Staphylococcus aureus clones. European journal of clinical microbiology & infectious 
diseases, 31(12), 3317-3321.  
Ghaznavi-Rad, E., Shamsudin, M.N., Sekawi, Z., Khoon, L.Y, Aziz, M.N., Hamat, R.A., Ghasemzadeh-
M, H. (2010). Predominance and emergence of clones of hospital-acquired methicillin-resistant 
Staphylococcus aureus in Malaysia. Journal of Clinical Microbiology, 48(3), 867-872.  
Gosbell, I. B., & van Hal, S.J. (2013). Staphylococcus aureus colonisation: some questions answered. The 
Lancet Infectious Diseases, 13(5), 380-381. doi: http://dx.doi.org/10.1016/S1473-3099(13)70048-
3 
Graveland, H., Duim, B., Van Duijkeren., E, Heederik, D., & Wagenaar, J A. (2011). Livestock-
associated methicillin-resistant Staphylococcus aureus in animals and humans. International 
Journal of Medical Microbiology, 301(8), 630-634.  
Grema, H., Geidam, Y., Gadzama, G., Ameh, J., & Suleiman, A. (2015). Methicillin resistant 
Staphyloccus aureus (MRSA): a review. Adv. Anim. Vet. Sci, 3(2), 79-98.  
Group, H.P II Study. (1999). Methicillin-resistant Staphylococcus aureus in French hospitals: A 2-month 
survey in 43 hospitals, 1995. Infection control and hospital epidemiology: the official journal of 
the Society of Hospital Epidemiologists of America, 20(7), 478.  
Grundmann, H., Aanensen, D.M., Van Den W., Cees C., Spratt, B.G., Harmsen, D., Friedrich, A.W., & 
Group, European Staphylococcal Reference Laboratory Working. (2010). Geographic distribution 
of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological 
analysis. PLoS medicine, 7(1), 49.  
Hryniewicz, W. (1999). Epidemiology of MRSA. Infection, 27(2), S13-S16.  
Ito, T., Okuma, K., Ma, X. X., Yuzawa, H., & Hiramatsu., K. (2003). Insights on antibiotic resistance of 
Staphylococcus aureus from its whole genome: genomic island SCC. Drug Resistance Updates, 
6(1), 41-52.  
Katayama, Y., Ito, T., & Hiramatsu, K., (2000). A new class of genetic element, staphylococcus cassette 
chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrobial Agents 
and Chemotherapy, 44(6), 1549-1555.  
Köck, R., Becker, K., Cookson, B., van Gemert-Pijnen, J.E., Harbarth, S., Kluytmans, J., Struelens, M.J. 
(2010). Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control 
challenges in Europe.  
Kuhn, G., Francioli, P., & Blanc, D.S. (2006). Evidence for clonal evolution among highly polymorphic 
genes in methicillin-resistant Staphylococcus aureus. Journal of bacteriology, 188(1), 169-178.  
Kuhn, G., Francioli, P., & Blanc, D.S. (2007). Double-locus sequence typing using clfB and spa, a fast 
and simple method for epidemiological typing of methicillin-resistant Staphylococcus aureus. 
Journal of clinical microbiology, 45(1), 54-62.  
PJSRR (2016) 2(2): 121-134 
eISSN: 2462-2028  © Universiti Putra Malaysia Press 
 
133 
 
Larsen, J., Imanishi, M., Hinjoy, S., Tharavichitkul, P., Duangsong, K., Davis, M.F., Nelson, K.E., 
Larsen, A.R. and Skov, R.L., (2012). Methicillin-resistant Staphylococcus aureus ST9 in pigs in 
Thailand. PloS one, 7(2), p.e31245. 
Lencastre, H., Severina, E., P, Milch., Hedda, T., Marianne, K., & Tomasz, A. (1997). Wide geographic 
distribution of a unique methicillin‐resistant Staphylococcus aureus clone in Hungarian hospitals. 
Clinical Microbiology and Infection, 3(3), 289-296.  
Leonard, F.C., & Markey, B.K. (2008). Meticillin-resistant Staphylococcus aureus in animals: A review. 
The Veterinary Journal, 175(1), 27-36.  
Lindsay, J.A., & Holden, M.T.G. (2006). Understanding the rise of the superbug: investigation of the 
evolution and genomic variation of Staphylococcus aureus. Functional & integrative genomics, 
6(3), 186-201.  
Luzzago, C., Locatelli, C., Franco, A., Scaccabarozzi, L., Gualdi, V., Viganò, R., Sironi, G., Besozzi, M., 
Castiglioni, B., Lanfranchi, P. and Cremonesi, P., (2014). Clonal diversity, virulence-associated 
genes and antimicrobial resistance profile of Staphylococcus aureus isolates from nasal cavities 
and soft tissue infections in wild ruminants in Italian Alps. Veterinary microbiology, 170(1), 
pp.157-161. 
McBryde, E.S., Bradley, L.C., Whitby, M, & McElwain, D.L.S. (2004). An investigation of contact 
transmission of methicillin-resistant Staphylococcus aureus. Journal of Hospital Infection, 58(2), 
104-108.  
Mitsuda, T., Arai, K., Ibe, M., Imagawa, T., Tomono, N., & Yokota, S. (1999). The influence of 
methicillin-resistant Staphylococcus aureus (MRSA) carriers in a nursery and transmission of 
MRSA to their households. Journal of Hospital Infection, 42(1), 45-51. doi: 
http://dx.doi.org/10.1053/jhin.1998.0551 
Murchan, S., Kaufmann, M.E, Deplano, A., de Ryck, R., Struelens, M., Zinn, C.E., El Solh, N. (2003). 
Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains 
of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 
European laboratories and its application for tracing the spread of related strains. Journal of 
clinical microbiology, 41(4), 1574-1585.  
Musser, J.M., & Kapur, V. (1992). Clonal analysis of methicillin-resistant Staphylococcus aureus strains 
from intercontinental sources: association of the mec gene with divergent phylogenetic lineages 
implies dissemination by horizontal transfer and recombination. Journal of clinical microbiology, 
30(8), 2058-2063.  
Neela, V., Moghaddam, H.G., Van Belkum, A., Horst-Kreft, D., Mariana, N.S., & Rad, E.G. (2010). First 
report on methicillin-resistant Staphylococcus aureus of Spa type T037, Sequence type 239, 
SCCmec type III/IIIA in Malaysia. European journal of clinical microbiology & infectious 
diseases, 29(1), 115-117.  
Noto, M.J., Fox, Paige M., & Archer, G L. (2008). Spontaneous deletion of the methicillin resistance 
determinant, mecA, partially compensates for the fitness cost associated with high-level 
vancomycin resistance in Staphylococcus aureus. Antimicrobial agents and chemotherapy, 52(4), 
1221-1229.  
O’Mahony, R., Abbott, Y., Leonard, F.C., Markey, B. K., Quinn, P.J., Pollock, P. J., Fanning, S., 
Rossney, A.S. (2005). Methicillin-resistant Staphylococcus aureus (MRSA) isolated from 
animals and veterinary personnel in Ireland. Veterinary microbiology. 30; 109(3):285-96.  
Oliveira, D. C., & de Lencastre, H. (2002). Multiplex PCR strategy for rapid identification of structural 
types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob 
Agents Chemother, 46(7), 2155-2161.  
Pinter, D.M., Mandel, J., Hulten, K.G., Minkoff, H., & Tosi, M.F. (2009). Maternal-infant perinatal 
transmission of methicillin-resistant and methicillin-sensitive Staphylococcus aureus. American 
journal of perinatology, 26(2), 145-151.  
PJSRR (2016) 2(2): 121-134 
eISSN: 2462-2028  © Universiti Putra Malaysia Press 
 
134 
 
Pittet, D., Allegranzi, B., Sax, H., Dharan, S., Pessoa-S., Carmem L., Donaldson, L., & Boyce, J.M. 
(2006). Evidence-based model for hand transmission during patient care and the role of improved 
practices. The Lancet infectious diseases, 6(10), 641-652.  
Price, L.B., Stegger, M., Hasman, H., Aziz, M., Larsen, J., Andersen, P.S., Pearson, T., Waters, A.E., 
Foster, J.T., Schupp, J. and Gillece, J., (2012). Staphylococcus aureus CC398: host adaptation 
and emergence of methicillin resistance in livestock. MBio, 3(1), pp.e00305-11. 
Purrello, S.M., Daum, R.S., Edwards, G.F.S., Lina, G., Lindsay, J., Peters, G., & Stefani, S. (2014). 
Meticillin-resistant Staphylococcus aureus (MRSA) update: New insights into bacterial 
adaptation and therapeutic targets. Journal of Global Antimicrobial Resistance, 2(2), 61-69. doi: 
http://dx.doi.org/10.1016/j.jgar.2014.02.003 
Rasigade, J-P, & Vandenesch, F. (2014). Staphylococcus aureus: A pathogen with still unresolved issues. 
Infection, Genetics and Evolution, 21(0), 510-514. doi: 
http://dx.doi.org/10.1016/j.meegid.2013.08.018 
Saleha, A., & Zunita, Z. (2010). Methicillin resistant Staphylococcus aureus (MRSA): An emerging 
veterinary and zoonotic pathogen of public health concern and some studies in Malaysia. J Anim 
Vet Adv, 9(7), 1094-1098.  
Skov, R., Christiansen, K., Dancer, S.J, Daum, R.S., Dryden, M., Huang, Y-C., & Lowy, F.D. (2012). 
Update on the prevention and control of community-acquired meticillin-resistant Staphylococcus 
aureus (CA-MRSA). International journal of antimicrobial agents, 39(3), 193-200.  
Tomasz, A., & De Lencastre, H. (1997). Molecular microbiology and epidemiology: coexistence or 
alliance. prevention and control of nosocomial infections. Baltimore: Williams and Willkins, 309-
321.  
Van Cleef, B.A., Monnet, D.L., Voss, A., Krziwanek, K., Allerberger, F., Struelens, M., Zemlickova, H., 
Skov, R.L., Vuopio-Varkila, J., Cuny, C. and Friedrich, A.W., (2011). Livestock-associated 
methicillin-resistant Staphylococcus aureus in humans, Europe. Emerging Infectious Diseases, 
17(3), 502-505 
Van de Giessen, AW., van Santen-Verheuvel, M.G., Hengeveld, P.D., Bosch, V.D.T., Broens, E.M., & 
Reusken, C.B.E.M. (2009). Occurrence of methicillin-resistant Staphylococcus aureus in rats 
living on pig farms. Preventive veterinary medicine, 91(2), 270-273.  
van Duijkeren, E., Box, A., Heck, M., Wannet, W., Fluit, A., (2004). Methicillin-resistant staphylococci 
isolated from animals. Veterinary Microbiology.103, 91–97. 
Voss, A., Loeffen, F., Bakker, J., Klaassen, C., & Wulf, M. (2005). Methicillin-resistant Staphylococcus 
aureus in pig farming. Emerging  Infectious Diseases, 11(12), 1965-1966.  
Weese, JS., Dick, H., Willey, B.M., McGeer, A., Kreiswirth, B.N., Innis, B., & Low, D.E. (2006). 
Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and 
humans in veterinary clinics and in the household. Veterinary microbiology, 115(1), 148-155.  
Witte, W. (2009). Community‐acquired methicillin‐resistant Staphylococcus aureus: what do we need to 
know? Clinical Microbiology and Infection, 15(s7), 17-25.  
Zahar, J-R., & Timsit, J-F. (2007). How To Control MRSA Spread in the Intensive Care Unit Infectious 
Diseases in Critical Care (pp. 226-232): Springer. 
Zunita, Z., Bashir, A., & Hafizal, A. (2008). Occurrence of Multidrug Resistant Staphylococcus aureus in 
horses in Malaysia. Veterinary World, 1(6), 165-167.  
 
